Thomas James Kipps

This inventor holds 36 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Cancer Therapeutics. Top assignee: University of California. Active years: 2001-2026.

USPTO Granted Patents = 36 (Patent Applications = 9)

% Patents Active = 83.3

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 9 (Patent Applications = 13)

Average Co-Inventor Count = 3.1

ph-index = 10

Forward Citations = 258(Granted Patents)

Location History:

Ranchos Santa Fe, CA (US) (2001)
Rancho Sante Fe, CA (US) (2010)
Solana Beach, CA (US) (2006 - 2011)
Rancho Santa Fe, CA (US) (2009 - 2018)
San Diego, CA (US) (2012 - 2024)

Company Filing History:

36 out of 15,977

University of California

patents

Years Active: 2001-2026

Loading Chart...

Areas of Expertise:

ROR1 Antibodies

Cancer Treatment

Chimeric Polypeptides

Therapeutic Antibodies

Lymphoma Detection

Metastasis Inhibition

Chronic Lymphocytic Leukemia

Nucleic Acids

Vaccines

Combination Therapy

Antibody Detection

Ror1-Ror2 Binding

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12643947 - ANTI-ROR-2 ANTIBODIES AND METHODS OF USE (2026-06-02),

2. 12286480 - Modulators of ROR1-ROR2 binding (2025-04-29),

3. 12222355 - Therapeutic antibodies against ROR-1 protein and methods for use of same (2025-02-11),

4. 12162950 - Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis (2024-12-10),

5. 11883492 - Combination treatment of chemoresistant cancers (2024-01-30),

6. 11654193 - Cancer treatment combinations (2023-05-23),

7. 11548953 - Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereof (2023-01-10),

8. 11536727 - Therapeutic antibodies against ROR-1 protein and methods for use of same (2022-12-27),

9. 11312787 - Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis (2022-04-26),

10. 10921329 - Methods for detecting antibodies (2021-02-16),

11. 10913798 - Modulators of ROR1-ROR2 binding (2021-02-09),

12. 10900973 - Therapeutic antibodies against ROR-1 protein and methods for use of same (2021-01-26),

13. 10688181 - Cancer treatment combinations (2020-06-23),

14. 10627409 - Therapeutic antibodies against ROR-1 protein and methods for use of same (2020-04-21),

15. 10359432 - Methods for detecting antibodies (2019-07-23),

Title: Thomas James Kipps: Innovator in Cancer Treatment

Introduction

Thomas James Kipps is a prominent inventor based in San Diego, CA, recognized for his substantial contributions to the field of cancer research. With 33 patents to his name, Kipps is dedicated to developing innovative treatments that enhance the quality of care for patients facing challenging diagnoses.

Latest Patents

Among his latest patents are groundbreaking innovations in the treatment of ROR1 cancers. One such invention focuses on antibodies and vaccines designed to inhibit metastasis. Specifically, this pharmaceutical composition utilizes anti-ROR1 antibodies, antigen-binding fragments, and ROR1-binding peptides to provide a method of inhibiting cancer spread.

Additionally, Kipps has contributed to the combination treatment of chemoresistant cancers, especially breast cancer. His patent details comprehensive compositions and methods that involve administering a therapeutically effective amount of a chemotherapeutic agent, such as paclitaxel, alongside a ROR-1 antagonist, cirmtuzumab, to enhance treatment efficacy.

Career Highlights

Kipps is currently affiliated with the University of California, where his research and innovations in cancer treatment are making significant impacts. His work not only demonstrates his expertise but also his commitment to advancing healthcare through innovative patentable inventions.

Collaborations

Throughout his career, Kipps has collaborated with esteemed colleagues, including Bing Cui and George F. Widhopf II. Their joint efforts highlight the importance of teamwork in the pursuit of breakthroughs in medical science.

Conclusion

Thomas James Kipps exemplifies the spirit of innovation within the medical field, particularly in the fight against cancer. With a robust portfolio of patents and a collaborative approach, he continues to pave the way for groundbreaking treatments that hold promise for patients battling complex diseases.